These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 9714700)
1. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells. Tsukamoto N; Chen J; Yoshida A Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700 [TBL] [Abstract][Full Text] [Related]
2. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Sreerama L; Sladek NE Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125 [TBL] [Abstract][Full Text] [Related]
3. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues. Andersson BS; Mroue M; Britten RA; Murray D Cancer Res; 1994 Oct; 54(20):5394-400. PubMed ID: 7923171 [TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype. Chen G; Teicher BA; Frei E Cancer Biochem Biophys; 1998 Jun; 16(1-2):139-55. PubMed ID: 9923973 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Moreb J; Schweder M; Suresh A; Zucali JR Cancer Gene Ther; 1996; 3(1):24-30. PubMed ID: 8785707 [TBL] [Abstract][Full Text] [Related]
6. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Dirven HA; van Ommen B; van Bladeren PJ Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469 [TBL] [Abstract][Full Text] [Related]
7. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315 [TBL] [Abstract][Full Text] [Related]
8. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line. Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987 [TBL] [Abstract][Full Text] [Related]
9. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro. Moreb JS; Maccow C; Schweder M; Hecomovich J J Pharmacol Exp Ther; 2000 May; 293(2):390-6. PubMed ID: 10773007 [TBL] [Abstract][Full Text] [Related]
12. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402 [TBL] [Abstract][Full Text] [Related]
13. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [TBL] [Abstract][Full Text] [Related]
14. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line. el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434 [TBL] [Abstract][Full Text] [Related]
15. Aldehyde-dehydrogenase gene-transduced hematopoietic cell line K562 overcomes the cytoxicity of cyclophosphamide in vitro. Yang XW; Wang W; Fu JX; Cen JN; Guo F; Xia XM; Chen ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):205-8. PubMed ID: 12513786 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine. Maki PA; Sladek NE Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438 [TBL] [Abstract][Full Text] [Related]
17. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines. Sladek NE; Landkamer GJ Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623 [TBL] [Abstract][Full Text] [Related]
18. The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme. Stewart MJ; Malek K; Xiao Q; Dipple KM; Crabb DW Biochem Biophys Res Commun; 1995 Jun; 211(1):144-51. PubMed ID: 7779080 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239 [TBL] [Abstract][Full Text] [Related]
20. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. Sreerama L; Sladek NE Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]